Onkologie. 2024:18(5):322-324 | DOI: 10.36290/xon.2024.067

PICC-port: a novel type of long-term venous access device for cancer patients

Viktor Maňásek
Komplexní onkologické centrum a Kanylační centrum Nemocnice Agel, Nový Jičín
Společnost pro porty a permanentní katétry, Praha

The PICC-port is a novel type of long-term venous access device that is increasingly indicated for use because of the reduced risk of complications during insertion and excellent aesthetic effect when compared with a chest port. It is the next generation of ports that has replaced the previously inserted arm or brachial ports in which inappropriate implantation hindered their widespread use due to high rates of complications. When modern recommendations are followed, the PICC-port can become the first-choice venous access in specific clinical situations.

Keywords: PICC-port, anticancer treatment, venous access, oncology.

Accepted: November 18, 2024; Published: November 28, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Maňásek V. PICC-port: a novel type of long-term venous access device for cancer patients. Onkologie. 2024;18(5):322-324. doi: 10.36290/xon.2024.067.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Brescia F, Annetta MG, Pinelli F, et al. A GAVeCeLT bundle for PICC-port insertion: The SIP-Port protocol. J Vasc Access. 2023 Nov 13:11297298231209521. doi: 10.1177/11297298231209521. Epub ahead of print. PMID: 37953715. Go to original source... Go to PubMed...
    2. Liu Y, Li LL, Xu L, et al. Comparison between arm port and chest port for optimal vascular access port in patients with breast cancer: a systematic review and meta-analysis. Biomed Res Int. 2020;2020:9082924. Go to original source... Go to PubMed...
    3. Bertoglio S, Annetta MG, Brescia F,et al. A multicenter retrospective study on 4480 implanted PICC-ports: A GAVeCeLT project. J Vasc Access. 2022 Jan 17:11297298211067683. doi: 10.1177/11297298211067683. Epub ahead of print. PMID: 35034480. Go to original source... Go to PubMed...
    4. Bertoglio S, Cafiero F, Meszaros P, et al. PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy. J Vasc Access. 2020;21(4):460-466. Go to original source... Go to PubMed...
    5. Brescia F, Pittiruti M, Spencer TR, et al. The SIP protocol update: Eight strategies, incorporating Rapid Peripheral Vein Assessment (RaPeVA), to minimize complications associated with peripherally inserted central catheter insertion. J Vasc Access. 2024;25(1):5-13. doi: 10.1177/11297298221099838. Epub 2022 May 27. PMID: 35633065; PMCID: PMC10845830. Go to original source... Go to PubMed...
    6. Nifong TP, McDevitt TJ. The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters. Chest. 2011;140(1):48-53. Go to original source... Go to PubMed...
    7. Dawson RB. PICC Zone Insertion Method™ (ZIM™): a sys tematic approach to determine the ideal insertion site for PICCs in the upper arm. J Assoc Vasc Access. 2011;16(3):156-165. Go to original source...
    8. Ostroff MD, Moureau N, Pittiruti M. Rapid assessment of vascular exit site and tunneling options (RAVESTO): a new decision tool in the management of the complex vascu lar access patients. J Vasc Access. 2023;24(2):311-317. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.